Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Solutions × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 5 Tumor-Agnostic 1 Sarcoma 1 Other hematologic neoplasm 1 Gynecologic 1 Endocrine 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 299 Paclitaxel 266 Cyclophosphamide 248 Docetaxel 238 Capecitabine 198 Carboplatin 183 Letrozole 161 Fulvestrant 157 Doxorubicin 144 Bevacizumab 123 Anastrozole 104 Tamoxifen 102 Vinorelbine 97 pembrolizumab 96 Gemcitabine 94 Epirubicin 94 pertuzumab 92 exemestane 90 Albumin-Bound Paclitaxel 79 Lapatinib 76 Radiotherapy 72 130-nm albumin-bound paclitaxel 69 eribulin 66 palbociclib 65 Cisplatin 58 pyrotinib 54 Taxes 53 Everolimus 48 Drug Therapy 44 Goserelin 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03024580 2019-08-15

MEGA

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡